119 related articles for article (PubMed ID: 27787595)
1. Reproducibility of measurement of myometrial invasion in endometrial carcinoma.
van der Putten LJ; van de Vijver K; Bartosch C; Davidson B; Gatius S; Matias-Guiu X; McCluggage WG; Toledo G; van der Wurff AA; Pijnenborg JM; Massuger LF; Bulten J
Virchows Arch; 2017 Jan; 470(1):63-68. PubMed ID: 27787595
[TBL] [Abstract][Full Text] [Related]
2. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
[TBL] [Abstract][Full Text] [Related]
3. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.
Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A
Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
6. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?
Lindauer J; Fowler JM; Manolitsas TP; Copeland LJ; Eaton LA; Ramirez NC; Cohn DE
Gynecol Oncol; 2003 Dec; 91(3):547-51. PubMed ID: 14675674
[TBL] [Abstract][Full Text] [Related]
7. Endometrial serous carcinoma: A retrospective review of histological features & their clinicopathological association with disease-free survival & overall survival.
Agarwal A; Yadav S; Dusane R; Menon S; Rekhi B; Deodhar KK
Indian J Med Res; 2022 Jul; 156(1):83-93. PubMed ID: 36510901
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.
Scholten AN; Smit VT; Beerman H; van Putten WL; Creutzberg CL
Cancer; 2004 Feb; 100(4):764-72. PubMed ID: 14770433
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters.
Kapucuoglu N; Bulbul D; Tulunay G; Temel MA
Int J Gynecol Cancer; 2008; 18(4):790-6. PubMed ID: 17892460
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors in endometrial cancer.
Doghri R; Chaabouni S; Houcine Y; Charfi L; Boujelbene N; Driss M; Mrad K
Mol Clin Oncol; 2018 Jul; 9(1):87-91. PubMed ID: 29896403
[TBL] [Abstract][Full Text] [Related]
11. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of myometrial invasion in endometrial carcinoma.
Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
[TBL] [Abstract][Full Text] [Related]
13. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
Ali A; Black D; Soslow RA
Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of myometrial invasion in endometrial carcinoma].
Peng P; Shen K; Lang J; Huang H; Wu M; Cui Q; Jiang Y; Tan L
Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):679-82. PubMed ID: 12487925
[TBL] [Abstract][Full Text] [Related]
15. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
Suh DS; Kim JK; Kim KR; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Acta Obstet Gynecol Scand; 2009; 88(9):990-3. PubMed ID: 19636979
[TBL] [Abstract][Full Text] [Related]
16. Transvaginal ultrasound assessment of myometrial and cervical stromal invasion in women with endometrial cancer: interobserver reproducibility among ultrasound experts and gynecologists.
Eriksson LS; Lindqvist PG; Flöter Rådestad A; Dueholm M; Fischerova D; Franchi D; Jokubkiene L; Leone FP; Savelli L; Sladkevicius P; Testa AC; Van den Bosch T; Ameye L; Epstein E
Ultrasound Obstet Gynecol; 2015 Apr; 45(4):476-82. PubMed ID: 25092412
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
[TBL] [Abstract][Full Text] [Related]
18. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
Stokes GN; Shelton JB; Zahn CM; Kendall BS
Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
[TBL] [Abstract][Full Text] [Related]
19. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
20. Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas.
Husby JA; Salvesen ØO; Magnussen IJ; Trovik J; Bjørge L; Salvesen HB; Haldorsen IS
Clin Radiol; 2015 May; 70(5):487-94. PubMed ID: 25639620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
